{"id":576387,"date":"2021-07-16T00:00:00","date_gmt":"2021-07-16T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/cutrcg0002-2021-biopharma-chronic-pain-current-treatment-us-2021\/"},"modified":"2026-04-24T11:26:09","modified_gmt":"2026-04-24T11:26:09","slug":"cutrcg0002-2021-biopharma-chronic-pain-current-treatment-us-2021","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/cutrcg0002-2021-biopharma-chronic-pain-current-treatment-us-2021\/","title":{"rendered":"Chronic Pain | Current Treatment | US | 2021"},"content":{"rendered":"<p>Clarivate&#8217;s primary market research explores how PCPs \/ pain specialists in the United States navigate the current treatment of chronic pain, with a focus on chronic back pain and OA pain.<\/p>\n","protected":false},"template":"","class_list":["post-576387","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-chronic-pain","biopharma-product-current-treatment","biopharma-geography-us","biopharma-date-950"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/576387","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/576387\/revisions"}],"predecessor-version":[{"id":577566,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/576387\/revisions\/577566"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=576387"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}